Search Results
Jul 27, 2026, 23:28 ET MCBS DATA BREACH ALERT: Edelson Lechtzin LLP Launches Investigation into Exposure of Personal Information
individuals impacted by MCBS cybersecurity incident AUGUSTA, Ga., July 27, 2026 /PRNewswire/ -- Edelson Lechtzin LLP, a national class action law firm, is investigating data privacy claims arising from the MCBS (Medical Computer
More news about: Edelson Lechtzin LLP
Jul 24, 2026, 16:00 ET METROCITY BANKSHARES, INC. REPORTS EARNINGS FOR SECOND QUARTER 2026
ATLANTA, July 24, 2026 /PRNewswire/ -- MetroCity Bankshares, Inc. ("MetroCity" or the "Company") (NASDAQ: MCBS), holding company for Metro City Bank (the "Bank"), today reported net income of $22.1 million, or $0.76 per diluted share, for the second quarter of
More news about: MetroCity Bankshares, Inc.
Jul 15, 2026, 16:00 ET MetroCity Bankshares, Inc. Declares Quarterly Cash Dividend
ATLANTA, July 15, 2026 /PRNewswire/ -- MetroCity Bankshares, Inc. (the "Company") (NASDAQ: MCBS) announced today that its board of directors declared a quarterly cash dividend of $0.29 per share on its common stock. The cash dividend is payable
More news about: MetroCity Bankshares, Inc.
May 14, 2026, 11:00 ET From Transformation to Triumph: Monterey County Bank Hits Profitability Milestone
clubs, and economic development groupsSupporting financial literacy and community-focused initiativesThese efforts reinforce MCB's mission to be truly embedded in the community while contributing to Monterey County's long-term prosperity.Brand Refresh:As part
More news about: Monterey County Bank
Apr 24, 2026, 16:00 ET METROCITY BANKSHARES, INC. REPORTS EARNINGS FOR FIRST QUARTER 2026
ATLANTA, April 24, 2026 /PRNewswire/ -- MetroCity Bankshares, Inc. ("MetroCity" or the "Company") (NASDAQ: MCBS), holding company for Metro City Bank (the "Bank"), today reported net income of $22.3 million, or $0.77 per diluted share, for the first quarter of
More news about: MetroCity Bankshares, Inc.
Apr 15, 2026, 16:00 ET MetroCity Bankshares, Inc. Declares Quarterly Cash Dividend
ATLANTA, April 15, 2026 /PRNewswire/ -- MetroCity Bankshares, Inc. (the "Company") (NASDAQ: MCBS) announced today that its board of directors declared a quarterly cash dividend of $0.29 per share on its common stock. The cash dividend is payable
More news about: MetroCity Bankshares, Inc.
Apr 06, 2026, 13:10 ET Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines
regulators start asking hard questions. With a qualified MCB now in place, Avaí Bio and Austrianova have that foundation locked in."MCBs are a prerequisite for the production of Cell-in-a-Box® encapsulated cell products," said Prof. Walter H. Gunzburg, Chairman of Austrianova.
More news about: USA News Group
Apr 06, 2026, 09:00 ET Abbott recebe aprovação regulatória no Brasil de serplulimabe, novo medicamento biológico para o tratamento de câncer de pulmão de pequenas células com doença extensa, oferecendo uma nova alternativa para pacientes
Sociedade Europeia de Oncologia Médica (ESMO) atribuiu ao serplulimabe a pontuação de 4 em 5 em sua Escala de Magnitude do Benefício Clínico (MCBS)13 para a primeira linha de CPPC-DE, refletindo seu potencial terapêutico para os pacientes.Com 135 anos de história e quase 90 anos de presença
More news about: Abbott
Mar 31, 2026, 20:49 ET The $578 Billion Regenerative Medicine Market Has a Manufacturing Problem. One Company Just Solved the First Step
backed by over 50 peer-reviewed publications and decades of clinical development.Prof. Walter H. Gunzburg, Chairman of Austrianova, said: "MCBs are a prerequisite for the production of Cell-in-a-Box® encapsulated cell products. They provide the foundation for sustainable production and ensure
More news about: USA News Group
Mar 27, 2026, 09:15 ET Scalable Biotech Manufacturing Unlocks a $14B Market
regulators start asking hard questions. With a qualified MCB in place, Avaí and Austrianova now have that foundation locked in."MCBs are a prerequisite for the production of Cell-in-a-Box® encapsulated cell products," said Prof. Walter H. Gunzburg, Chairman of Austrianova.
More news about: USA News Group
Mar 24, 2026, 10:00 ET Advanced Cell-based Therapy Booming the Success for Healthcare Sector
working cell banks and therapy development for the Klothonova program will proceed.Prof. Walter H. Gunzburg, Chairman of Austrianova, said: "MCBs are a prerequisite for the production of Cell-in-a-Box® encapsulated cell products. They provide the foundation for sustainable production
More news about: USA News Group
Mar 18, 2026, 10:00 ET A Key "Master" Protein That Declines by Half After Age 40. One Company Found a Way to Restore It.
treatments for aging associated diseases," said Chris Winter, CEO of Avaí Bio.Prof. Walter H. Gunzburg, Chairman of Austrianova, added: "MCBs are a prerequisite for the production of Cell-in-a-Box® encapsulated cell products. They provide the foundation for sustainable production
More news about: Equity Insider
Mar 17, 2026, 09:00 ET Apertura Gene Therapy and Viralgen Announce Strategic Collaboration to Manufacture TfR1 CapX, a Next-Generation Capsid for Gene Therapies Designed to Treat Central Nervous System Diseases
Bank (MCB) creation and plasmid supply as part of its integrated AAV manufacturing services. Currently, these capabilities are utilized to generate MCBs and plasmids for the TfR1 CapX partnership."Through this collaboration, Apertura licensees can benefit from an efficient and fast supply of TfR1
More news about: Viralgen
Mar 17, 2026, 09:00 ET Apertura Gene Therapy and Viralgen Announce Strategic Collaboration to Manufacture TfR1 CapX, a Next-Generation Capsid for Gene Therapies Designed to Treat Central Nervous System Diseases
Bank (MCB) creation and plasmid supply as part of its integrated AAV manufacturing services. Currently, these capabilities are utilized to generate MCBs and plasmids for the TfR1 CapX partnership."Through this collaboration, Apertura licensees can benefit from an efficient and fast supply of TfR1
More news about: Viralgen
Mar 17, 2026, 09:00 ET Apertura Gene Therapy und Viralgen kündigen strategische Zusammenarbeit zur Herstellung von TfR1 CapX an, einem Kapsid der nächsten Generation für Gentherapien zur Behandlung von Erkrankungen des zentralen Nervensystems
Bank (MCB) und die Bereitstellung von Plasmiden als Teil seiner integrierten AAV-Herstellungsdienste. Derzeit werden diese Möglichkeiten genutzt, um MCBs und Plasmide für die TfR1 CapX-Partnerschaft zu erzeugen.„Durch diese Zusammenarbeit können die Lizenznehmer von Apertura von einer effizienten
More news about: Viralgen
Mar 03, 2026, 10:02 ET Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them
treatments for aging associated diseases," said Chris Winter, CEO of Avaí Bio.Prof. Walter H. Gunzburg, Chairman of Austrianova, added, "MCBs are a prerequisite for the production of Cell-in-a-Box® encapsulated cell products. They provide the foundation for sustainable production and ensure
More news about: USA News Group
Mar 03, 2026, 09:00 ET Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B Milestone
aging associated diseases," said Chris Winter, Chief Executive Officer of Avaí Bio.Prof. Walter H. Gunzburg, Chairman of Austrianova, added, "MCBs are a prerequisite for the production of Cell-in-a-Box® encapsulated cell products. They provide the foundation for sustainable production
More news about: Market News Updates
Mar 03, 2026, 08:30 ET Avaí Bio and Austrianova Begin Production of Master Cell Bank for Klotho Anti-Aging Therapy Under GMP Standards
associated diseases," said Chris Winter, Chief Executive Officer of Avaí Bio. Prof. Walter H. Gunzburg, Chairman of Austrianova, added, "MCBs are a prerequisite for the production of Cell-in-a-Box® encapsulated cell products. They provide the foundation for sustainable production
More news about: Avaí Bio, Inc.
Feb 25, 2026, 08:53 ET The Mauritius Commercial Bank Limited successfully closes its USD 450 million Syndicated Term Loan Facility
USD 450 million, reflecting sustained confidence in MCB's credit fundamentals.Structured as a two-year term loan with a one-year extension option at the borrower's discretion (2+1), the facility enhances funding flexibility and optimises MCB's maturity profile. Strong market support also enabled
More news about: MCB Group
Feb 25, 2026, 08:47 ET The Mauritius Commercial Bank Limited successfully closes its USD 450 million Syndicated Term Loan Facility
USD 450 million, reflecting sustained confidence in MCB's credit fundamentals.Structured as a two-year term loan with a one-year extension option at the borrower's discretion (2+1), the facility enhances funding flexibility and optimises MCB's maturity profile. Strong market support also enabled
More news about: MCB Group
Feb 17, 2026, 07:05 ET Metropolitan Commercial Bank Completes ACH Cloud Migration Powered by Finzly in Landmark Move
Bank's Modern Banking in Motion initiative and marks a milestone in an industry seeking alternatives to aging payment infrastructure. MCB's migration demonstrates that full ACH cloud modernization—long considered too complex for most banks—is now achievable. Several financial institutions
More news about: Finzly
Jan 30, 2026, 08:15 ET METROCITY BANKSHARES, INC. REPORTS EARNINGS FOR FOURTH QUARTER AND YEAR ENDED 2025
ATLANTA, Jan. 30, 2026 /PRNewswire/ -- MetroCity Bankshares, Inc. ("MetroCity" or the "Company") (NASDAQ: MCBS), holding company for Metro City Bank (the "Bank"), today reported net income of $18.3 million, or $0.68 per diluted share, for the fourth quarter of
More news about: MetroCity Bankshares, Inc.
Jan 22, 2026, 06:59 ET Low Voltage DC Circuit Breaker Market worth $2.52 billion by 2030 | MarketsandMarkets™
expertise, broad low-voltage product portfolio, and strong capabilities in DC power protection technologies. Its offerings include DC-rated MCCBs, MCBs, disconnectors, load break switches, and solar-specific DC protection devices, designed to meet stringent global safety and performance standards. The
More news about: MarketsandMarkets
Jan 21, 2026, 16:14 ET MetroCity Bankshares, Inc. Declares Quarterly Cash Dividend
ATLANTA, Jan. 21, 2026 /PRNewswire/ -- MetroCity Bankshares, Inc. (NASDAQ: MCBS) announced today that its board of directors declared a quarterly cash dividend of $0.25 per share on its common stock. The cash dividend is payable
More news about: MetroCity Bankshares, Inc.
Jan 07, 2026, 16:15 ET MCB Real Estate Requests Response from Whitestone REIT Board of Trustees Regarding Compelling, All-Cash Acquisition Proposal
approximately $4 billion in AUM, today sent a letter to the Board of Trustees of Whitestone REIT (NYSE: WSR) ("Whitestone" or the "Company") regarding MCB's previously announced proposal to acquire all of the outstanding shares of Whitestone REIT for $15.20 per share in cash, with no financing contingency.
More news about: MCB Real Estate